Pan, Xiangyu
Cai, Yudong
Li, Zongjun
Chen, Xianqing
Heller, Rasmus
Wang, Nini
Wang, Yu
Zhao, Chen
Wang, Yong
Xu, Han
Li, Songhai
Li, Ming
Li, Cunyuan
Hu, Shengwei
Li, Hui
Wang, Kun
Chen, Lei
Wei, Bin
Zheng, Zhuqing
Fu, Weiwei
Yang, Yue
Zhang, Tingting
Hou, Zhuoting
Yan, Yueyang
Lv, Xiaoyang
Sun, Wei
Li, Xinyu
Huang, Shisheng
Liu, Lixiang
Mao, Shengyong
Liu, Wenqing
Hua, Jinlian
Li, Zhipeng
Zhang, Guojie
Chen, Yulin
Wang, Xihong
Qiu, Qiang
Dalrymple, Brian P.
Wang, Wen
Jiang, Yu
Article History
Received: 17 August 2020
Accepted: 29 September 2020
First Online: 5 November 2020
Ethics
: <b>Compliance and ethics</b> Two provisional Chinese patent applications on potential application in the antimicrobial and antibiotic substitute by way of the DEFB1 gene and LYZ1 gene have been filed by Northwest A&F University (application number 202010100677.8 and 202010097562.8), where Y.J., X.P., X.C, and W.W. are listed as inventors. The author(s) declare that they have no conflict of interest.